top of page

ANAVEX New Website - Untitled Page.png

News, Events and Updates

Search

Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental Disorders

Jan 8

Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental Disorders

Anavex Life Sciences Announces Its Very First Scientific Educational Video News Release

Jun 20, 2022

Anavex Life Sciences Announces Its Very First Scientific Educational Video News Release

Anavex’s Publication Supports Clinical Biomarker for ANAVEX®2-73 in Fragile X Syndrome

Jun 8, 2022

Anavex’s Publication Supports Clinical Biomarker for ANAVEX®2-73 in Fragile X Syndrome

Stay Connected

Follow us on social media

Webcast Library

Back to Newsroom

bottom of page